Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
Exploration of an mRNA based nanovaccine platform and immunopeptidomics for the development of more effective tuberculosis vaccines.
Information
Project Team
Organisations
Outputs and Outcomes
Code
DOCT/003719
Duration
22 March 2021 → 20 September 2026 (Ongoing)
Doctoral researcher
Ilke Aernout
Research disciplines
No data available
Project description
No data available